Compare Mutual Funds

Pros
5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

Among most bought funds within the category.

Among most bought funds within the category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
1/8
8/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

13 Years 8 Months

13 Years 8 Months

Fund AUM

₹4566 Cr

₹8636 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.91%

0.79%

Exit Load

0.5%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

36

37

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(11.03%)
  2. Divi's Laboratories Ltd(6.57%)
  3. Acutaas Chemicals Ltd(6.17%)
  4. Apollo Hospitals Enterprise Ltd(5.37%)
  5. Max Healthcare Institute Ltd Ordinary Shares(4.76%)
  1. Sun Pharmaceuticals Industries Ltd(13.35%)
  2. Lupin Ltd(7.31%)
  3. Dr Reddy's Laboratories Ltd(6.72%)
  4. Cipla Ltd(6.16%)
  5. Divi's Laboratories Ltd(5.8%)
No of Sectors

3

1

Top 3 Sectors
  1. Health(90.95%)
  2. Basic Materials(9.05%)
  3. Government(2.52%)

Health

(100%)

Equity %

97.49%

97.92%

Debt %

0.06%

-

P/E

47.87

36.71

P/B

6.47

5.41

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

6.12%

4.2%

3-Month Return

20.37%

13.38%

6-Month Return

15.1%

8.62%

1-Year Return

14.1%

8.22%

3-Year Return

25.2%

21.57%

5-Year Return

17.36%

13.69%

Sharpe

1.21

0.97

Alpha

2.71

-0.78

Beta

0.86

0.89

Standard Deviation

14.59

15.23

Information Ratio

0.16

-0.76

Description

SBI Healthcare Opportunities Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Tanmaya Desai

Amber Singhania, Kinjal Desai, Sailesh Raj Bhan

Most Popular Comparisons